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Patients with generalized atrophic benign epidermol-
y sis bullosa (GABEB), an inherited subepidern'131 blis-
tering disease, often have no immunologically de-
tectable bullous pemphigoid antigen 2 (BPAG2) in 
t heir epidermal basement membrane. Recently, we 
analyzed the BPAG2 gene (GenBank no. M91669) in 
an Austrian family with GABEB and identified a 
homozygous deletion mutation, 4003de1TC, that re-
sults in a downstream premature termination codon 
(PTC). This mutation has now been identified in 
additional descendants, suggesting transmission of 
this mutant allele through at least six generations. 
Screening of four other Austrian GABEB families 
revealed that affected members were homozygous for 
4003delTC in two cases and heterozygous in two 
others. In the latter, mutational analysis identified 
two novel nonsense mutations, Q1403X and G803X, 
that were confirmed by restriction endonuclease di-
gestions. Thus, PTCs on both alleles of BPAG2 are 
B ullous pemphigoid antigen 2 (BPAG2) is a l S0-kDa, type II transmembrane protein that is associ~ted with hemidesmosomes in basal keratinocytes (Dlaz et ai, 1990; Giudice et ai, 1992). Amino acid sequences deduced from BPAG2 cDNAs indicate that the extra-
cellular portion of this protein consists of 15 domains of Gly-X -Y 
repeats characteristic of those present in various collagen mole-
cules. H ence, BPAG2 is also referred to as type XVII collagen 
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present in all of these GABEB families. Immunopre-
cipitation and northern blot studies of cultured kera-
tinocytes from homozygous GABEB patients show 
that 4003delTC results in undetectable levels of 
BPAG2 protein and mRNA-findings consistent with 
the process of nonsense-mediated mRNA decay. in-
cubating keratinocytes with cycloheximide increased 
BPAG2 mRNA to a level detectable by northern 
analysis. When the latter was used in reverse tran-
scription-PCR studies, the mutation was demon-
strated, suggesting that cycloheximide may allow 
mutational analysis in cases where low transcript 
levels have previously thwarted RT-PCR studies. 
These findings account for the absence ofBPAG2 in 
GABEB patients and attest to the importance of this 
protein in adhesion of epidermis to epidermal base-
ment membrane. Key words: heritable blistering diseasesl 
basement membYaJtelhemidesmosomeslmJttatioll/COL17 A 1. 
J Invest Deymatol 108:463-468, 1997 
(C0L17 A1) (Li et ai, 1991 , 1993) . In basal keratinocytes, BPAG2 is 
thought to play a key role in the adhesion of epidennis to epidennal 
basement m embrane (BM) . Evidence in favor of this view has been 
derived from studies of acquired and inherited subepidermal blis-
tering diseases in w hich impairments in BPAG2 are associated with 
separation of epidermis from epidermal BM (yancey, 1995) . For 
example, BPAG2 is the antigen recognized by cir culating autoan-
tibodies in patients with bullous pemphigoid and herpes gestationis 
as w ell as some patients with cicatricial pemphigoid (Diaz et ai, 
1990; Balding et ai, 1996). Moreover, experimental animal models 
indicate that antibodies directed against cer tain portions ofBPAG2 
can elicit subepidermal blisters ill viJlo (Liu et aI, 1993, 1995). 
R ecent studies identifying mutations in the BPAG2 gene in patients 
with generalized atrophic benign epidennolysis (GABEB) , an in-
herited subepidermal blistering disease, further attest to the fund a-
mental role that this protein plays in keratinocyte adhesion to 
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Figure 1. (A-E) Pedigrees offive families with GABED. The prescnce 
or absence of a deletion mntation i.n BPAG2, 4003dc1TC, was determined 
by restriction cndonuclease digestion (see Materials alld Methods) . Opell 
sYlllbols represent wlaffected individua ls who are negative for 4003de1TC. 
Filled sYlllbols are affected individuals homozygous for 4003delTC. SYIIII)ol;-
with half black alld half white represent unaffected carriers of 4003de1TC. 
SYlll bols with a fi lle stipple arc those individuals from whom D NA was not 
available for analysis. Mutations in BPAG2 other than 4003deiTC were 
fo und in the fathers and affected individuals of f.lmilies D and E (detailed in 
Figs 2,3) and are shown as diago/wl lilies and a checkerboard paltem, 
respectively. 
epiderm al BM (McGrath et ai, 1995a, 1996a, 1996b; Gatalica et ai, 
1997). 
GABEB is one of the first welJ characterized nonlethal sub-
types of junctional epidernlolysis bullosa (Schnyder and Anton-
Lamprecht, 1979; Hintner and Wolff, 1982). GABEB is inherited in 
an autoso,';'a] recessive pattern and is characterized by generalized 
blistering of the skin and mucous membranes, atroph.ic scarring, 
alopecia, dystrophic nails, and dysplastic teeth . In addition, some 
patients have "GABEB nevi," large melanocytic nevi that develop 
at sites of prior blisters. R ecent studies have identified diminished 
o r absent expression ofBPAG2 in the lesional and nonlesional skin 
of patients with GABEB Oonkman et ai, 1995; Pohla-Gubo et ai, 
1995; Jonkman et ai, 1996). Moreover, our groups have recently 
identified mutations in th e BPAG2 gene in two families with 
GABEB (McGrath e/ ai, 1995a, 1996a). T he aims of the current 
study were to conduct a mutational analysis of the BPAG2 gene in 
five well characterized Austrian families with GABEB and deter-
mine the biologic consequences of these mutations at the molecular 
level. 
MATERlALS AND METHODS 
Patients Five families were evaluated in this study, including eight 
patients ,.,jth GAllEB, 14 unaffected siblings and their offspring, and nine 
parents (Fig 1). The families were not known to be related. All GAllEB 
patients had the fo llowing characteristic featurcs: (i) surviva] in to adulthood 
despite gene ralized b listering since birth; (ii) atrophic scarring, alopecia, 
dystrophic nails, and abnormal dentition (as well as so-called "GAllEB 
nevi" in fo ur of the families); (iii) subepidermal blisters that formed within 
the lamina lucida of cpidermal BM as demonstrated by electron microscopy 
and / or immunofluorescence mapping; and (iv) an autosomal recessive 
pattern of inheritance. In addition, indirect immunofluorescence micros-
copy studies were used to demonstrate that H018 monoclona l anti-BPAG2 
antibody (a gift of Dr. Monica Liebert, Houston, TX, and Dr. George 
Giudice , Milwaukee, W I) showed no reactivity to the epidennal BM of any 
GAllEB patient in this stud y. In normal human skin, HD18 bound 
epidernlal BM in a bright, continuo us pattern as previous ly described 
(Pohla-Gubo ct. aI , 1995). Control immunofluorescence microscopy studies 
fo und that bullous pemph.igoid antigen 1 (BPAG1), laminin 5, types IV and 
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VII collagen, and integrin subunits a 2 , a 3 , {3 t, a(" and {3" were expressed in 
the same pattern in both GAllEB and normal human skin . 
Identification of 4003delTC A recently cbaracterized mutation in 
BPAG2, 4003delTC, could be readily detected because tlus genetic lesion 
introduces a novel N lalll restriction endonuclease site at tI,C deletion 
(McGrath et aI, 1996a). For these studies, genomic DNA was isolated from 
peripheral blood by phenol/chloroform extraction and amplified by the 
polymerase chain reaction (PCR) using intron-specific primers; the ampli-
fied product was digested with N laIll and analyzed in 3% agarose gels as 
previously described (McGrath et aI, 1996a) . 
Mutational Analysis Using DNA from the parents and the affected 
individuals, the 56 exom ofBPAG2 (GenBank no. M91669) (Giudice et nl, 
1992) were amplified by pCR using primers based on flanking intronic 
sequences (Gatali cn et aI, 1997). The primer sequences for exons containing 
the mutations documented in tlus report were as follows: (i) for tile 
paternally inherited mutation in exon 53 (a 138-bp exon encompassing 
nucleotides 4262 to 4399 in the cDNA) in Fanuly D, the sense primer was 
5'-CACTGTGCTCCTGCTGAAGA-3 ' and the anti-sense primer was 5 ' -
TATCCAGTGAGGCAGGTGCT-3' (size of expected amplification prod-
uct = 252 bp); and (ii) for the paternally inherited mutation in ex on 34 (a 
36-bp ex on encompassing nucleotides 2504 to 2539) in Fanuly E, the sense 
primer was 5' -GTCCCAAATGCAATCAGAAG-3 ' and the anti-sense 
primcr was 5' -CA TGGAACA TTGAGCCCTAC-3 ' (size of amplification 
product = 356 bp) . Amplification conditions were as reported previously 
(McGrath ef. aI, 1996a), the only exception being a change in "'lIlealing 
temperature from 55°C to 60°C when using the primers corresponding to 
exon 34. Heteroduplcx analyses wcre performed on hydrolink gels accord-
ing to the manuf.lcturer's recommendations (J-1ydrolink MDE Gel, j.T. 
Baker, Inc., Phillipsburg, NJ). PCRproducts showing a beteroduplex in tile 
father and affected individuals were doned into the pN oTA/T7 vector 
(PrimePCR C loner C loning System,S Prime -> 3 Prime, Inc., Boulder, 
CO) and then sequenced using an ABI Prism automated sequencer (Perkin-
Elmer, Branchburg, NJ). 
Mutation Verification Sequencing results were confirmed by tI,C anal-
ysis of new restriction endouuclease sites created in mutated alleles. For 
Families D and E, the mutations resultcd in [lew restriction sites for Nltel 
(GIBCO BRL, Gaithersburg, MD) and NlaITI (New England Biolabs, 
Beverly, MA), respectively. For tI,ese confirmatory experiments, 10 /Ll of 
the appropriate PCR products from all family members were digested 
according to the manufacturer's recommendations and then electropho-
resed on 20% polyacryl"'nide ge ls (Novex 20% TBE gel, San Diego CAl, 
using GelMarker (Research Genetics, Inc., Huntsville AL) as a standard . 
Keratinocyte Cultures Epidermal sheets were obtained from tltree 
affected individuals by applying shear pressure to a circular area (2-3 Clll 
diameter) on ti,e forearm. Epidermal cell suspensions were crea ted with 
0.25% trypsin , an d keratinocytes were cultured in serum-free medium 
(Keratinocyte-SFM , GIBCO BRL) as previo usly described (Basset-Seguin d 
aI, 1990) . Contro l human keratillocytes were cnltured from the foreskins of 
healtby newborns. 
Immunoprecipitation SubconBuent monolayer cultures of keratino-
cytes from patients with GAllEB or normal neonatal foreskins were 
biosYllthcticaUy radiolabeled with e SS]mctluOlune (50 /LCi per ml; specific 
activity, - 1100 Ci/mmol; New England Nuclear , Boston, MA) in methi-
otune-free medium. R adiolabeled cell extracts were processed as previously 
described (Domloge-Hultsch ct aI, 1992) and studied by immunoprecipita-
tion using rabbit ""tiserum developed again st a baculovirus-encoded re-
combinant form of BPAG2; positive and negative con trols cons isted of 
rabbit antiserum to a bacterial fusion pro tein ofBPAG1 (a gift from Dr. Jolm 
R. Stanley, Philadelplua, PAl and pre-immune rabbit serum , respectively. 
Northern Blots Total RNA was extracted from subconfluent cultures of 
keratillocytes from three patients with GAllEB or nonllailleonatal foreskins 
as previously described (Sambrook ef. aI, 1989). These studies included 
samples of total RNA from cultnres of GAllEB and normal human 
keratinocytes maintained in 10 /Lg of cycloheximide per ml for 2.5 h. 
Approximately 5 /Lg of total ceBular RNA were fractionated by electro-
pho resis through 1 % agarose/formaldehyde dellaturing gels and transferred 
to Nytran membranes (Schleicher & Schuell, Keene, NH) by capillary 
elution . RNA-containing membranes were cross-linked by ultraviolet ligbt 
(UV Stratalinker, Stratagene, La J o lla, CAl tllen pre-hybridized at 42°C for 
4 h in Hibrisol J (Oncor, Gaithersburg, MO). Membranes were hybridized 
ovenught at 42°C with 20 to 40 ngpf a randomly primed 32P-labeled cDNA 
probe for a non collagenous regi9n of BpAG2 (cDNA nucleotides 730 to 
1585; specific activities, 108 to 10" cpm/ /Lg), washed wlder increasingly 
strin gent conditions, and then exposed to Biomax MR film (Kodak, 
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F igure 2 . Identification of a nonsense m u tation (Q 1403X) in family D . (A) H eteroduplex ana lysis of exon 53 shows a heteroduplex band (~) in 
addition to the hom oduplcx in the father and the affected individual , but only the homoduplex band in the m o ther, unaffected sibling, and unrelated con trol. 
(B) Nucleo tide sequcncin g of clones of the PCR product rcveals a C -to-T transition in the mutant allele at n ucleo tide position 43 12, con ve.rting a g lutamine 
residue ~AG) to a stop codon C!AG) . (C) R estri ction en donuclease digestion verifi es the mutation by the introduction of a n ew N heJ site in the mutan t 
alle le. In the control, moth er, and unaffected sibling, the 252-bp PC R product is n o t cnt by NI,e!. In the fa ther and affected individual , bands of 129 and 123 
bp are visible in addi tion to the 252-bp band , consistent with heterozygosity fo r the mutation. 
Rochester, NY) w ith intcnsifying screens at - 70°C for va rio us times. 
Following hybridiza ti on with thc BPAG2 eDNA probe, m embranes were 
stripped and re-hybridized with a radiolabeled human {3-actin cDNA 
fragm ent (Clontcch Laboratories, Inc. , Palo Alto, C Al to assess uniformity 
of RNA loadin g aud transfcr. 
Reverse Tran scriptio n-Polymerase Chain Reaction (RT-PCR) 
Aliquo ts of total RNA (- 0.5 ILg) fro m G ABEB keratinocytcs or no rmal 
keratinocytcs incubated in the prescncc o r absence of l 0 ILg cycloheximide 
p er 1111 werc mixed with rando m hexam ers and reverse tran scribed to 
produce eDNAs tha t we re subsequently mixed w ith primers fo r BPAG2 and 
amplified by PC R (GcncAmp RNA PCR , Pcrkin-Elm er). C onditions w ere 
accordin g to the m an uL1ctUl'ers recommendations except that the aIU1eal-
extend temperature w as changed to 55°C fo r tile 25 cycles . Primer pairs for 
amplifica ti on o f BPAG2 cDNA corrcsponded to nucleotides 38 53 to 3880 
and 4610 to 4630. T hese primers span part of exon 51, exons 52 to 56, and 
31 bp o f the 3' -un translated region ; tlu s encompasses exon 52, wluch 
co ntains the 4003delTC mut"tion and the resul ting premature ternunation 
co don (pTC) 86 bp downstream . Amplimers fo r human {3-acti.l1 w ere used 
as a control (Clontcch Laborato ries, Inc. , Palo Al to, CAl. 
RESULTS 
Identification o f 4003delT C Members of five well character-
ized GABEB families were tested for the presence of 4003de1TC, a 
recently described 2-bp deletion mutation in the BPAG2 gene 
(M cGrath et ai, 1996a), by N lalIl res triction endonuclease digestion 
of PCR-amplified geno.mic DNA. Initial studies focused on previ-
B 
ously untes ted individuals frOI11 Family A, the kindred originally 
shown to possess tllis mutation . These studies identifi ed fi ve 
unaffected ind.ividuals as carriers for 4003delTC, including the 
mother of the original probands, two o f her children , and two of 
her grandchildren (Fig 1A). Interes tingly, the mother of one of 
these grandchildren did not possess 4003de1TC, suggesting that the 
fatller, who had common ancestry Witll his spouse back several 
generations (Hintner and Wolff, 1982), was the source of this 
m utant allele . These findings confinn the original clinical pedigree 
of tllis kindred and suggest that 4003delTC has been transmitted 
through at least six generations. 
Similar analyses were performed in four additional w1.l'ela ted 
fanli lies (Families B-E) . R estriction endonuclease digestion of 
PCR-amplified DNA from Families B and C found tlla t affected 
individuals were homozygous for 4003delTC and that each o f these 
patient' s parents was a carrier of tllis l11utation (Fig 1B, q . In 
Families D and E, affected individuals were found to be heterozy-
gous for 4003de1TC, and the l11utan t allele in both families was 
shown to be carried by the mother (Fig 1D,E). T hese fi ndings 
suggested that the affected individuals were compound heterozy-
go tes and that their paternally inherited alleles possessed a different 
mutation in BPAG2. 
I d en t ification of a C-to-T Transi t ion at Nucleotide Position 
4312 in Family D H eteroduplex an alysis on H ydrolink gels was 
Normal G T Mutant 
A 
C 
356 bp 
253 bp 
103 bp 
C STO 
-----
500 bp 
300 bp 
100 bp 
G A AC C A G GAG e T C 
140 1 
G A AC CA T GAG C T C 
140 150 
F igure 3. Identification of a nonsense m u tation (G803X) in family E . (A) H eteroduplex analysis of ex on 34 shows a heteroduplex baIld (~) in 
ad di tion to the ho m oduplcx in tile father and ti le affccted individual , but only the hOll1oduplex band in tile lTIo tllCr and unrel ated control. (B) N uclcotide 
sequencing of clones of the PC R product reveals a G-to-T transversion in th e lTIutant allele at nucleo tide position 251.2, conver ting a glycine residue (gGA) 
to a stop codon (!GA) . (C) R estric tion endonuclease digesti on verifies the mutation by the introduction of a new N laIll site in til e mu tant allelc . In the 
contro l aIld m o ther, the 356-bp PC R product is no t cut by NlaH!. In tile fa tll er and affected individual , bands of 253 aI1d 103 bp are visible in addi tion to 
the 356-bp band, consistent Witll heterozygosity fo r the mutation . 
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Figure 4. Immunoprecipita-
tion of biosynthetically radio-
labeled extracts from GABEB 
and normal cultured keratino-
cytes show absence ofBPAG2 
in GABEB keratinocytes. A 
rabbit polycJonal antibody to a 
baculovirus-encoded recombinant 
form ofBPAG2 precipitates a 180-
kDa band in normal keratinocytes 
but not GABEB keratinocytes. As 
a positive control, rabbit poly-
clonal antibody to a BPAG1 fusion 
protein precipitates a 230-kDa 
band in both normal and GABEB 
keratinocytes . No bands are visible 
using pre-immune rabbit serum. 
performed to identify the region of the BPAG2 gene that contained 
the paternally inherited mutation in Family D. These studies found 
that the PCR-amplified DNA corresponding to nucleotides 4262 to 
4399 (exon 53) of the BPAG2 cDNA showed a heteroduplex in the 
father and the affected individual, but not in the mother, an 
unaffected sibling, or an unrelated control (Fig 2A). To identify the 
genetic lesion in this region, tlus PCR product was cloned into the 
pNoTA/T7 vector, and both alleles were sequenced. These studies 
identified a C-to-T transition at nucleotide position 4312 that 
converts the codon for a glutamine residue (!:;AG) to a nonsense 
codon (IAG) and is therefore designated Q1403X (Fig 2B). 
Because Q1403X creates a new restriction endonuclease site for 
NlleI (G/CTAGC in the mutant and GCCAGC in the normal), it 
was possible to directly confirm this mutation in PCR-amplified 
DNA from individuals in Fan1.ily D as well as unrelated patients 
with GABEB. Amplification of the exon containing this mutation as 
well as adjacent flanking intronic sequences yielded a PCR product 
of 252 bp. When PCR-amplified DNA from the father or the 
affected individual in Family D was subjected to Nile! digestion, 
bands of 252, 123, and 129 bp were identified as expected for 
individuals heterozygous for Q1403X (Fig 2C). In contrast, Nile! 
digestion of amplified DNA from the mother, a sibling, and an 
unrelated control showed only the 252-bp band as expected for 
individnals who are homozygous for the normal allele. Q1403X 
was not identified in the proband of Family E. 
Identification of a G-to-T Transversion at Nucleotide 2512 
in Family E Heteroduplex analysis was also performed to iden-
tify the region of the BPAG2 gene that contained the paternally 
inherited mutation in Family E. These studies identified a hetero-
duplex in the father and his affected son in PCR-amplified DNA 
corresponding to nucleotides 2504 to 2539 (exon 34) of the BPAG2 
cDNA (Fig 3A). This heteroduplex was not identified in PCR-
amplifIed DNA from the patient's mother or an unrelated control 
(Fig 3A) . Sequencing of these alleles demonstrated a G-to-T 
transversion at nucleotide 2512 in tillS affected individual (Fig 3B). 
This transversion converts a glycine residue (gGA) to a nonsense 
codon (IGA) and hence is designated G803X. 
G803X generates a NlaIII restriction site in the mutant allele 
(CATG/N in the mutant and CAGGN in the normal) that allows 
confirmation of this mutation in PCR-amplified DNA from Family 
E. Amplification of the 36-bp exon 34 containing tillS mutation as 
well as adjacent, flanking intronic sequences yielded a PCR product 
of356 bp. When the PCR-amplified DNA from the father and his 
affected son was subjected to Nlalll digestion, bands of 356, 103, 
and 253 bp were identified, as expected for individuals who are 
heterozygous for G803X (Fig 3C). In contrast, NlaIII digestion of 
similarly amplified DNA from the patient's mother and an unre-
lated nor111al control showed only the 356-bp PCR product, as 
expected for individuals who are homozygous for the normal allele. 
Biologic Consequences of 4003deiTC Biosynthetically radio-
labeled extracts of subconfluent keratinocyte cultures from two 
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Figure 5. Northern blot analysis of 
total RNA isolated from GABEB 
and normal keratinocytes reveals 
110 detectable BPAG2 mRNA in 
GABEB keratinocytes unless the 
cells are incubated with cyclohex-
itnide. Keratinocytes were cultured 
for 2.5 h in the absence (-) or presence 
(+) of cycloheximide (CHX)(10 J.l..g 
per ml) before isolating total RNA. 
Normal keratinocytes show a single 
band ofBPAG2 mRNA at 6.0 kb, and 
cycloheximide has little effect on the 
intensity of tlus band. In contrast, no 
BPAG2 mRNA is detected in GABEB 
keratinocytes unless the cells are incu-
bated ill the presence of cyclohexillude. 
The /3-actin probe demonstrates rela-
tively tlIuform loading and transfer of 
RNA. 
affected individuals in Family A (as well as normal neonatal foreskin 
controls) were studied by iml11unoprecipitation using rabbit anti-
serum directed agaulst BPAG1 and BPAG2 (as well as pre-immune 
rabbit serum as a control). WIllIe normal kerati.l1ocytes produced 
the expected l80-leDa BPAG2 protein, there was no evidence of 
BPAG2 or a truncated form of this protein in GABEB keratinocytes. 
The hen1.idesmosome-associated protein, BPAG1, was identifIed in 
keratinocytes from both patients with GABEB and normal controls 
(Fig 4). 
To further characterize the biologic consequences of 4003delTC, 
total RNA was extracted from subconfluent cultures of GABEB 
and normal keratinocytes and studied by northern blot analysis 
usulg a probe specific for the 5' portion of BPAG2 (specifically, 
nucleotides 730-1585). These studies found no evidence ofBPAG2 
mRNA Ul keratinocytes from three GABEB patients, in contrast to 
the expected 6.0-kb species present in extracts ofnonnal keratino-
cytes (Fig 5). Interestingly, the absence of detectable BPAG2 
mRNA Ul GABEB keratinocytes changed when these cells were 
treated with cyclohexin1.ide (10 J.Lg per rnJ), an inhibitor of protein 
synthesis. Cyclohexin1.ide treatment increased the level of the 
6.0-kb transcript for BPAG2 in GABEB keratinocytes. This tran-
script co-nugrated in 1% agarose/formaldehyde gels with BPAG2 
mRNA present in normal keratinocytes. Control experiments 
ntilizing a human {3-actin probe confirmed the uniforn1.ity of RNA 
loading and transfer in all northern blot studies. 
Findings in our northern blot studies suggest that BPAG2 mRNA 
levels in GABEB keratinocytes would preclude mutational analyses 
via RT-PCR. To devise a new strategy for detection of GABEB 
BPAG2 mRNA, verify the mutation thereul, and assess its conse-
quences on · the processing of BPAG2 transcripts, we reverse 
transcribed total RNA from cycloheximide-treated GABEB (or 
normal) keratinocytes and amplified cDNA for study. BPAG2 
transcripts were readily detectable using total RNA extracted from 
normal keratinocytes, as shown by the expected 778-bp product 
amplified from the reverse-transcribed cDNA (Fig 6). Only a faint 
band for BPAG2 was obtained, however, using total RNA from 
GABEB keratinocytes. When GABEB keratinocytes were UICU-
bated Ul the presence of cyclohexin1.ide, RT-PCR of total RNA 
demonstrated an intense single band of the expected size (Fig 6). 
Control amplimers for {3-actin mRNA produced 838-bp bands that 
were equally intense under all the conditions tested. T he presence 
of a single band of the expected size in GABEB keratinocytes 
demonstrates that the 4003delTC mutation does not result in 
skipping of the exon containing the PTC, as has been observed for 
certain PTCs in other genes (WilJ et ai, 1995). This conclusion was 
further strengthened by NlaIlI digestion of the RT -PCR products, 
which confirmed the presence of the 4003delTC mutation in 
BPAG2 transcripts from cyclohexin1.ide-treated GABEB keratino-
cytes. As expected based on the nucleotide sequence, the RT-PCR 
product from normal cells was cleaved into fragments of 223, 182, 
- ---------- ---- -- ---- -
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Figure 6. RT-PCR of total RNA shows amplification of GABEB 
keratinocyte BPAG2 cDNA in the presence of cycloheximide 
(CHX), and NlaIll digestion demonstrates the presence of the 
mutation in the RT-PCR product. Primers were used to amplify the 
cDNA for either J3-actin or BPAG2 (specifically the region encompassing 
the 4003deiTC mutation in BPAG2). The amplified cDNA for BPAG2 was 
also digested with Nianl. A 778-bp product for BPAG2 was obtained using 
total RNA from nonnal keratinocytes, and digestion with NlaIII gave the 
expected bands of223, 182, 132, 129, 87, and 25 bp. Although a faint band 
at 778 bp is visible using total RNA from GABEB keratinocytes, pre-
incubation of the cells with cycloheximide greatly enhances its detection. 
Digestion with Niall! confirms the mutation by the absence of the 182-bp 
band and appearance of bands of148 and 32 bp. (Because of their small size, 
the bands of 25 and 32 bp are visible only with prolonged exposure and 
hence are not shown ill tllis figure). 
132, 129, 87, and 25 bp (Fig 6). The mutation 4003deiTC 
introduces a new restriction site for NlallI, which would be 
expected to cut the 182-bp fragment into pieces of148 and 32 bp. 
NlallI digestion of the RT-PCR product from GABEB keratino-
cytes incubated in the presence of cycloheximide yielded bands of 
223, 132, 129, 87, and 25 bp, with absence of the 182-bp fragment 
and appearance of bands of 148 and 32 bp (Fig 6). Tlus demon-
strates that the RT -PCR product did not result from contamination 
with normal RNA and confirms that the mutation did not result in 
an unexpected pattern of exon splicing. 
DISCUSSION 
Patients with GABEB have recurrent blistering and skin fragility 
beginning at birth or during the early neonatal period. Most 
patients with tlus phenotype have been shown to lack BPAG2 in 
their epidermal BMs. Two patients with tIle same phenotype, 
however, have been shown to have nornlal BPAG2, yet defective 
expression oflaminin 5 (a3133'}'2) (McGrath et ai, 1995b; Jonkman 
et ai, 1996) . In one case, tlus form of GABEB was traced to a 
mutation in tlle gene endoding the 133 subunit of laminin 5 
(McGrath et ai, 1995b). The common phenotype (i.e., GABEB) 
resulting from these two genotypes suggests that the two adhesion 
molecules in question are likely to be closely associated in human 
epidermal BM. Current models of epidennal BM suggest that tillS 
is the case. 
In this study we show that affected individuals from five unre-
lated families with GABEB have impaired epidennal adhesion as a 
consequence of mutations in the gene encoding BPAG2. Further-
more, the three different BPAG2 mutations documented in these 
individuals all result in PTCs on both alleles. Although one 
previously reported BPAG2 mutation is a glycine substitution, 
(McGrath et ai, 1996b), the other documented mutations in this 
gene result in PTCs (McGrath et ai, 1995a, 1996b; Gatalica ef ai, 
1997). Mutations resulting in PTCs are commonly observed in 
some of the other forms of epidermolysis bullosa. For example, in 
the lethal (Herlitz) form of junctional epidermolysis bullosa, PTCs 
in both alleles of the LAMA3, LAMB3, or LAMC2 genes (which 
code for the a3, 133, and y2 chains of laminin 5, respectively) 
underlie all cases reported to date (Christiano and Uitto, 1996). 
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SinUlarly, in the most severe forms of recessive dystropluc epider-
molysis bullosa, PTCs in the gene for type VII collagen (COL7 A1) 
have been identified in each case (Christiano and Uitto, 1996). It is 
interesting to note that altllough GABEB patients demonstrate the 
occurrence ofPTCs in the BPAG2 gene, their phenotype is much 
less severe than patients with PTCs in laminin 5 genes or in 
COL7 A1. This suggests tllat BPAG2 may function cooperatively 
with other hemidesmosomal proteins in promoting epidermal 
adhesion . Consistent witll tillS, mutations in another hemidesmo-
somal protein, integrin subunit 134' have also been identified in a 
patient with another form of junctional epidennolysis bullosa (Vidal 
et ai, 1995) . 
The biologic consequences of a PTC in tbe BPAG2 gene were 
investigated for individuals homozygous for 4003de1TC. One 
nught expect that tlus PTC located near the carboxy terminus of 
this type II transmembrane protein results in production of a 
truncated polypeptide. ImmwlOprecipitation studies of cultured 
keratinocytes from two GABEB patients utilizing a rabbit poly-
clonal antibody specific for BPAG2, however, found no detectable 
BPAG2 species of any size even though epitopes recognized by tlus 
antibody are upstream from the site of the PTC. Although de-
creased stability of a truncated protein is a possible explanation, 
northern blot studies of total RNA extracted from cultured kera-
tinocytes from three patients show no detectable BPAG2 mRNA 
and hence explain the absence of BPAG2 protein. These northern 
blot studies represent more summary data than in the existing 
literature. Moreover, the existing literature contains some difter-
ences. Specifically, one report of a single GABEB patient with 
defective expression of BPAG2 (mutation undefined) found low 
levels of a normal 6.0-kb mRNA transcript as well as a 4.9-kb 
BPAG2 mRNA species in GABEB keratinocytes Oonkman et ai, 
1995). Corroborating our findings, one other previously reported 
GABEB patient (a compowld heterozygote for PTCs in BPAG2) 
has been shown to have an absence ofBPAG2 n1.RNA in cultured 
keratinocytes by northern blot (McGratll ef aI, 1995a). 
The very low or undetectable levels of BPAG2 mRNA in 
keratinocytes from tl1.ese patients is consistent with nonsense-
mediated mRNA decay, a process leading to low abundance of 
mRNAs containing PTCs (Maquat, 1995). Interestingly, a recent ill 
vitro study has shown that cyclohe,,:imide has the ability to reverse 
the downregulation of PTC-bearing traJ1Scripts in cell lines stably 
transfected with constructs containing PTCs (Carter et ai, 1995). 
Building on tlus ell."}Jerimental observation, we demonstrated that 
cycloheximide can repress nonsense-mediated mRNA decay in 
GABEB keratinocytes (because this treatment resulted in the 
appearance ofBPAG2 mRNA in tllese cells). Moreover, we were 
able to exploit tlus effect of cyclohexin1ide in mutational analysis. 
Tlus is of significance because low or absent levels of mRNA can 
preclude the use of RT-PCR as the first step in generating 
measurable amounts of the DNA of interest. In sllch cases, muta-
tional analysis generally cannot proceed muess the genonuc struc-
ture is known, and even tllen can be hampered by tile presence of 
a homologous pseudogene (Forms tone et aI, 1995). The complexity 
of gene structuTe can also make analysis difficult, as is the case for 
BPAG2 where there are numerous exons separated by large introns 
(Gatalica et aI, 1997). Mutational analysis from cDNA can therefore 
greatly reduce the number of separate regions of DNA to be 
examined. In tlus study, we have demonstrated that cycloheximide 
treatment increased the levels of BPAG2 mRNA, and therefore 
provides the basis for an altemative strategy for mutational analysis. 
Furthermore, these experiments confirmed that tile PTC did not 
result in skipping of the exon containing tile PTC, as reported for 
certain PTCs in other genes (Will et ai, 1995). 
The tllree different mutations described in tillS report account for 
the absence of BPAG2 in the skin of eight patients fi'om five 
unrelated Austrian fanUUes with GABEB. Prelinunary studies indi-
cate that the 4003deiTC mutant allele present in all five of these 
families has common intra genic and flanking nucrosatellite poly-
morphisms - findings suggestive of a founder effect (Darling et al, 
unpubHshed observations). The biologic consequence of 4003 
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deLTC as well as these other non sense mutations on both aJJeles of 
the BPAG2 gene of these patients is a complete " knockout" of this 
gene product. This abnormali ty results in chronic blistering and 
skin fragiUty, affirming the importance of BPAG2 in maintaining 
the adhesion of epidermis to the epidermal BM. T he absence of this 
hernidesmosomal protein is also associated with the development of 
nail dys trophy, enamel hypoplasia, patchy alopecia, and, in some 
patients, melallocytic lesions. T hese findings imply that BPAG2 
plays inlportant roles in additional aspects of epithelial ce ll biology. 
Tllis stlldy lVas slIpporcell ill pnrt by tile UI/it ed Stntes PI/blic H enltll Sen' ice, 
N ntiO//(/1 Jllstitllles oj Henltlt C rnllt 1'0 1 A JU8923, nlllillt" Dermnlology FOlllldn-
liol/. Tile alltllors ,i/(/Ilk Han)' Sclla~rcr Jor preparil/g ,It" ilillstraliol/s. 
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